Author:
Yogaratnam Dinesh,Carey Katherine M.,Coppenrath Valerie,Dawson Aimee,Harris Morgan,LaMothe Amy B.W.,Pourhosseini Pourya,Lynch Ann M.
Reference58 articles.
1. Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial;Acharya;Rheumatology International,2020
2. Cardiovascular safety of the tyrosine kinase inhibitor nintedanib;Ameri;British Journal of Clinical Pharmacology,2021
3. Nintedanib-induced colitis treated effectively with budesonide;Amini;Cureus,2020
4. Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: A retrospective, observational, cohort study;Antoniou;ERJ Open Research,2020
5. Pirfenidone-induced dose-dependent phototoxicity—A distinct drug reaction;Arunprasath;Indian Dermatology Online Journal,2020